Qingyan Sandy Au
Principal Scientist, NeoGenomics
Date: 17 March 2021 (Wednesday)
Time: New York – 11:00 | London – 16:00 | Paris – 17:00 | Singapore – 00:00 (18 March) |Tokyo – 01: 00 (18 March) |Sydney – 03:00 (18 March)
Duration: 45 minutes
Event structure: 35-minute presentation + 10-minute Q&A
Registration fee: Complimentary access
Webinar on-demand: Available to view until midnight 31 March 2021 (registration is required)
Dr. Au is a Principal Scientist with the Pharma Services division at NeoGenomics, and has been working with the MultiOmyxTM technology platform for 8 years. Prior to joining NeoGenomics she was a Staff Scientist at Sanford Burnham Prebys Medical Discovery Institute, and previous to that was a Research Scientist at CytRx Corporation. Dr. Au earned her PhD in Biomedical Sciences from the University of California at Riverside, and she also holds Master’s degree in Genetics from Fudan University. Dr. Au has over 10 years of experience in multiplexed immunofluorescence (mIF) assay development & validation. Her work focuses on development and validation of mIF assays to characterize the tumor microenvironment in solid tumors as well as hematological malignancies.
With over a decade of experience in hosting life science events, Global Engage is your ideal partner to devise an agenda, source speakers, and build an audience.